The CAR-T Therapy Tisagenlecleucel Is Safe in Secondary CNS Lymphoma.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2019-116
Abstract: Tisagenlecleucel has an acceptable safety profile and showed preliminary evidence of CNS efficacy. read more here.
Keywords: safe secondary; cns; car therapy; tisagenlecleucel ... See more keywords